Pharmaceutical Firms Consider New Ways to Evaluate Wholesale Distribution Partners

The domestic pharmaceutical firms are looking to move away from the existing evaluation method that has influenced the contractual relationships with their wholesale distribution partners, in which the standard industry practice is to establish different set of distribution agreements, including the wholesale margins, primarily based on the external size, or capacity, of the wholesalers.

The...